What is Rds?
RDS is an innovative French company headquartered in Strasbourg, specializing in remote patient monitoring. The company develops, manufactures, and markets MultiSense®, a next-generation remote medical monitoring solution. Operating within the IHU, RDS leverages an international team and collaborates on major research projects such as DARE and 5G-OR, positioning itself at the forefront of medical technology innovation.
How much funding has Rds raised?
Rds has raised a total of $30.2M across 2 funding rounds:
Angel/Seed
$13.6M
Series A
$16.6M
Angel/Seed (2023): $13.6M with participation from Capital Grand Est
Series A (2025): $16.6M led by BPI France
Key Investors in Rds
Capital Grand Est
Capital Grand Est is a regional private equity management company based in France, managing investment and equity funds. Their participation suggests a focus on supporting regional economic development through strategic capital allocation.
BPI France
BPI France is the French public investment bank, supporting businesses in their growth and innovation initiatives. Their involvement indicates a strategic endorsement of Rds's technological advancements and market potential within France.
What's next for Rds?
The recent major strategic investment signals a pivotal growth phase for Rds. This financing is likely earmarked for scaling operations, expanding its technological capabilities, and potentially broadening its market reach. The company's focus on remote patient monitoring, coupled with its strategic research collaborations, suggests a trajectory aimed at solidifying its position as a leader in the digital health landscape. Future developments may include further product enhancements and strategic partnerships to capitalize on the growing demand for telehealth solutions.
See full Rds company page
